Tea and Forearm Blood Flow
Forearm Blood Flow Response to Acute Consumption of Black Tea
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The study will explore the benefit of tea for microcirculation. Subjects will consume tea ar a placebo matched for taste and appearance in a blinded cross over design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2014
CompletedFirst Posted
Study publicly available on registry
December 31, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedAugust 31, 2015
August 1, 2015
7 months
December 19, 2014
August 28, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Forearm blood flow response to acetylcholine
Does tea ingestion change mean forearm blood flow response to acetylcholine when compared to placebo
During acetylcholine infusion 120-140 min after first tea/placebo intake
Secondary Outcomes (2)
Forearm blood flow response to sodium nitropusside
During sodium nitropusside infusion 170-190 min after first tea/placebo intake
Forearm blood flow response to L-NMMA
During L-NMMA infusion 220-240 min after first tea/placebo intake
Study Arms (2)
Black tea
EXPERIMENTALApproximately 400 mg total polyphenols in 240 ml hot water (loading dose; 2 hours before the start of measurements; t=0) and 130 mg total polyphenols in 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)
Placebo
PLACEBO COMPARATORCaramel colour, maltodextrin and tea flavour in 240 ml hot water (2 hours before the start of measurements; t=0) and 120 ml hot water (maintenance dose just before start of the measurements; t=120 min)
Interventions
Eligibility Criteria
You may qualify if:
- Males and post menopausal (\> 1 years) females
- Aged ≥ 45 and ≤ 75 years
- Body mass index (BMI) of ≥ 18.0 and ≤ 35.0 kg/m2
- Judged to be in good health on the basis of medical history, physical examination and routine laboratory tests (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, highly sensitive C-reactive protein).
- Normal blood coagulation as assessed by routine lab tests
You may not qualify if:
- Strenuous exercise \> 2 hours per week. Strenuous exercise is defined as exercise which induces sweating and causes sufficient breathlessness to limit conversation
- Current smoker or has stopped smoking less than 6 months before start of study
- Self reported alcohol intake of \> 21 units/week)
- Established cardiovascular disease or clinically significant arrhythmia
- Diabetes mellitus
- Blood pressure \> 160/100 mmHg
- Taking medication that might affect endothelial function (as judged by the PI)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
- Radboud University Medical Centercollaborator
Related Publications (1)
Greyling A, Wolters TLC, de Bresser DM, Roerink SHPP, Riksen NP, Mulder TP, Rowson MJ, Hopman MT, Thijssen DHJ. The acute effect of black tea consumption on resistance artery endothelial function in healthy subjects. A randomized controlled trial. Clin Nutr ESPEN. 2018 Feb;23:41-47. doi: 10.1016/j.clnesp.2017.10.011. Epub 2017 Nov 8.
PMID: 29460812DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Roerink, Dr.
Radboud University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2014
First Posted
December 31, 2014
Study Start
January 1, 2015
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
August 31, 2015
Record last verified: 2015-08